Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera. [electronic resource]
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases Mar 2019
- 134-136 p. digital
Publication Type: Case Reports; Journal Article
1878-3511
10.1016/j.ijid.2019.01.002 doi
Aged Female Humans Male Mycobacterium Infections, Nontuberculous--drug therapy Mycobacterium avium--drug effects Mycobacterium tuberculosis--drug effects Nitriles Polycythemia Vera--drug therapy Primary Myelofibrosis--drug therapy Protein Kinase Inhibitors--therapeutic use Pyrazoles--therapeutic use Pyrimidines Tuberculosis--drug therapy